In particular, the binding of caveolin-1 to eNOS is a negative regulator of eNOS activity, and the hypercholesterolemia-induced decrease of NO production is probably due to enhanced interaction of caveolin-1 with eNOS [54,55], suggesting its involvement in endothelial dysfunction. The gene discussed is CAV1; the disease is endothelial dysfunction.